TCL Archive SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma September 29, 2006
TCL Archive NCI Looking At CCOP Budgets To Determine How Many Will Be Funded; Some Top Scorers Identified March 13, 1987
TCL Archive FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+. June 2, 2000
TCL Archive Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival April 27, 2012